COMPARISON OF SERUM INTERLEUKIN-6 (IL-6) LEVELS BETWEEN PATIENTS WITH HELLP SYNDROME VERSUS NORMOTENSIVE PREGNANT

Eugenius Phyowai Ganap

Abstract


Background: Interleukin-6 (IL-6) has been known associated with oxidative stress and endothelial dysfunction, and also has important roles in pathogenesis of preeclampsia. Several studies have demonstrated that there was a significant increase of serum IL-6 levels in preeclamptic compared to normotensive pregnant women. However, study to evaluate serum IL-6 level in pregnant women with HELLP (hemolysis, elevated liver enzyme, and low platelet) syndrome is not well documented yet. This study aims to evaluate serum IL-6 levels between women with HELLP syndrome compared to normotensive pregnant.

Methods: The research design was observational cross-sectional study. Samples were recruited consecutively using inclusion and exclusion criteria from emergency department and inpatient wards at Dr. Sardjito General Hospital, Yogyakarta, Indonesia. Serum IL-6 were collected from venous blood sample and measured by enzyme-linked immunoassay (ELISA) method. Independent-samples t-test or Mann-Whitney test was used to compare serum IL-6 values between women with HELLP syndrome and normotensive pregrnancy. A statistical measurement conducted using SPSS IBM Statistics 19® and considered significance when p<0,05.

Results: There were 46 subjects, consisted of 23 women with HELLP syndrome and 23 women with normotensive pregnancy. Serum IL-6 level was a mean of 0,11±0,08 pg/mL and 0,15±0,20 pg/mL in women with HELLP syndrome compared to normotensive pregnancy respectively. There was no significant statistical difference between both groups (p=0,17).

Conclusion:.The result of this study has shown that no significant difference of serum IL-6 level in HELLP syndrome women compared to normotensive pregnant women.

Keywords: Interleukin-6, HELLP syndrome, Preeclampsia, normotensive, hypertensive disorders


References


REFERENCES

Afshari, J.T., Ghomian, N., Shameli, A., Shakeri, M.T., Fahmidehkar, M.A., Mahajer, F., Khoshnavaz, R., Emadzadeh, M., 2005. Determination of interleukin-6 and tumor necrosis factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia. BMC Pregnancy Childbirth 5, 1–5. https://doi.org/10.1186/1471-2393-5-14

Ballin A, Osdachi A, Klivitsky A, Dalal I, Lishner M. 2006. “Age-Related Leukocyte and Cytokine Patterns in Community-Acquired Bronchopneumonia”. IMAJ, vol 8.

Didion, S.P., 2017. Cellular and oxidative mechanisms associated with interleukin-6 signaling in the vasculature. Int. J. Mol. Sci. 18. https://doi.org/10.3390/ijms18122563

Goulopoulou, S., Davidge, S.T., 2015. Molecular mechanisms of maternal vascular dysfunction in preeclampsia. Trends Mol. Med. 21, 88–97. https://doi.org/10.1016/j.molmed.2014.11.009

Greer, I.A., Lyall, F., Perera, T., Boswell, F., Macara, L.M., 1994. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet. Gynecol. 84, 937–940.

Jauniaux E, Gulbis B, Schandene L, Collette J, Hustin J. 1996. “Distribution of Interleukin-6 in Maternal and Embryonic Tissues During the First Trimester”. Molecular Human Reproduction vol.2 no.4 pp. 239-243

Lewis, D.F., Canzoneri, B.J., Gu, Y., Zhao, S., Wang, Y., 2010. Maternal Levels of Prostacyclin, Thromboxane, ICAM, and VCAM in Normal and Preeclamptic Pregnancies. Am. J. Reprod. Immunol. 64, 376–383. https://doi.org/10.1111/j.1600-0897.2010.00861.x

.

Lockwood, C.J., Yen, C.F., Basar, M., Kayisli, U.A., Martel, M., Buhimschi, I., Buhimschi, C., Huang, S.J., Krikun, G., Schatz, F., 2008. Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am. J. Pathol. 172, 1571–1579. https://doi.org/10.2353/ajpath.2008.070629

Lubrano, V., Baldi, S., Ferrannini, E., L’Abbate, A., Natali, A., 2008. Role of thromboxane A2 receptor on the effects of oxidized LDL on microvascular endothelium nitric oxide, endothelin-1, and IL-6 production. Microcirculation 15, 543–553.

Suzuki S, Tanaka K, Suzuki N. 2000. “Ambivalent Aspects of Interleukin-6 in Cerebral Ischemia: Inflammatory versus Neurotrophic Aspects. Journal of Cerebral Blood Flow & Metabolism. 29, 464–479

Vince, G.S., Starkey, P.M., Austgulen, R., Kwiatkowski, D., Redman, C.W., 1995. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br. J. Obstet. Gynaecol. 102, 20–25.

.




DOI: http://dx.doi.org/10.26532/sainsmed.v9i2.3630

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Sains Medika: Jurnal Kedokteran dan Kesehatan



Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at http://jurnal.unissula.ac.id/index.php/sainsmedika.

site
stats View My Stats.